BFC Planning’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
BFC Planning's AZN Position: Q3 2026 in Review
BFC Planning increased its AstraZeneca (AZN) stake by 1.2% in Q3 2026, buying an estimated $10K and bringing the position to 4,881 shares worth $788K. The position accounts for 0.03% of the portfolio, ranked #464.
BFC Planning first reported a position in AZN in Q3 2024 and has held it in 8 quarters since. The position peaked at $934K in Q1 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- BFC Planning held 4,881 shares of AstraZeneca worth $788K as of Q3 2026.
- BFC Planning bought 60 AstraZeneca shares in Q3 2026, an estimated $10K.
- AstraZeneca made up 0.03% of BFC Planning's portfolio in Q3 2026, its #464 holding.
- BFC Planning first reported a position in AstraZeneca in Q3 2024 and has held it in 8 quarters since.
- BFC Planning's AstraZeneca position peaked at $934K in Q1 2026.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.